Researcher to Founder Showcase (Manchester)
Join us for a fireside chat on company formation, a founder panel sharing real-world journeys from lab to startup, and networking with peers, mentors, and ecosystem builders, hosted by Prof. Sir Tony Kouzarides.
The programme will feature contributions from leaders across academia, venture capital and biotechnology, bringing together perspectives from research, investment and company building.
Speakers and Contributors
Prof Sir Tony Kouzarides – Founder of Storm Therapeutics, Chroma Therapeutics & Abcam ($5.6B acquisition); Venture Partner at Fifty Years
Steph Avraamides – Serial startup launchpad founder & UK Lead at Fifty Years
Vaitea Cowan - Founder of Enapter, Earthshot Prize Winner & UK Lead at Fifty Years
Prof Aline Miller – Professor & Associate Vice President (Enterprise) at The University of Manchester; Chief Scientific Officer at Unit M
James Reston – Investment Associate at DSW Ventures
Dr Ellie Goulding – Co-founder at Lanthagen Bio
Dr Sahara Bhanot – Co-founder at Lanthagen Bio
Designed for early-career researchers curious about having an impact and entrepreneurship, the event will dive into:
How to identify commercially viable, impactful ideas
The practical realities of company formation and early decision-making
Key factors in the academic → founder transition
Lessons learned from founders who’ve done it before
Hosted by PRIMED & Fifty Years UK team
5050 UK Programme
Sir Tony Kouzarides will also introduce 5050 UK, a free, 14-week, part-time company creation programme. Designed to help exceptional scientists and engineers explore whether founding a company could be the highest-impact path for their work. Powered by ARIA.
The programme offers hands-on mentorship, commercial validation, and access to an international network of 450 alumni who have founded over 100 impactful ventures. Since launching in March 2025, 5050 UK has supported 86 scientists and engineers, who've raised $11M+. Applications are open now for 5050 cohort 3 here.
5050 UK, and this event is powered by The Advanced Research + Invention Agency (ARIA), a UK R&D funding agency built to unlock scientific and technological breakthroughs that benefit everyone. ARIA empowers scientists and engineers, from their Programme Directors to the teams they fund, with the resources and freedom to pursue breakthroughs at the edge of the possible.
PRIMED UK is supported by Cancer Research Horizons, who support and fund innovative researchers and ventures tackling cancer.